Volume 15 Supplement 2

Treatment of SLE: bridging the gap from clinical trials to the clinic

Meeting abstracts

This supplement originates from a symposium held during the American College of Rheumatology congress in 2012, both of which were sponsored by the Cleveland Clinic Foundation Center for Continuing Education via an educational grant from Human Genome Sciences. Adapted transcripts of the presentations from the symposium, attached to the abstracts, are part of a CME activity. The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Cleveland Clinic Foundation designates these (4) enduring activities for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit. To claim CME credit, visit www.ccfcme.org/SLECMEsupplement. CME credit may be obtained upon reading all four CME-certified presentations online. The Cleveland Clinic Foundation Center for Continuing Education acknowledges educational grant for support of this activity from Human Genome Sciences. The CME activity associated with this supplement has now expired.

Treatment of SLE: bridging the gap from clinical trials to the clinic.

Washington, DC, USA11 November 2012